Concepedia

Inge M. Krul

IM

Statistics

Publications

4

Citations

714

H-Index

4

Active since

2015

Affiliations

The Netherlands Cancer Institute(Current)

Inserm

Centre de recherche en Epidémiologie et Santé des Populations

Leiden University Medical Center

Amsterdam UMC Location Vrije Universiteit Amsterdam

Inge M. Krul is an author at The Netherlands Cancer Institute specializing in medicine, oncology, and radiation therapy.

ORCID

Publications per year

2015–2022

4

Publications

4

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

Michael Schaapveld, Berthe M.P. Aleman, Anna M. van Eggermond et al. · New England Journal of Medicine · 2015 · 626 citations · Full text

, , +13

Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure

Inge M. Krul, Annemieke W. J. Opstal‐van Winden, Berthe M.P. Aleman et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 49 citations · Full text

, , +17

Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors

Sander Roberti, Flora E. van Leeuwen, Cécile M. Ronckers et al. · JNCI Journal of the National Cancer Institute · 2022 · 28 citations · Full text

, , +17

Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy

Nicola S. Russell, Inge M. Krul, Anna M. van Eggermond et al. · Clinical and Translational Radiation Oncology · 2017 · 11 citations · Full text

, , +17

1–4 of 4